No Effect of Bromocriptine in Acromegaly
- 11 June 1981
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 304 (24), 1450-1454
- https://doi.org/10.1056/nejm198106113042402
Abstract
Although bromocriptine, a dopamine receptor agonist, is now widely used in the treatment of acromegaly, there have been no controlled trials of its biochemical or clinical effects on this disorder. We assessed its effects in a double-blind, crossover study.Keywords
This publication has 21 references indexed in Scilit:
- RESPONSE OF ACROMEGALY TO LONG TERM BROMOCRIPTINE THERAPY: A BIOCHEMICAL AND CLINICAL ASSESSMENTActa Endocrinologica, 1978
- LONG-TERM TREATMENT OF ACROMEGALY WITH BROMOCRIPTINEActa Endocrinologica, 1978
- BROMOERGOCRYPTINE TREATMENT OF ACROMEGALY PERSISTING FOLLOWING CONVENTIONAL THERAPYClinical Endocrinology, 1978
- BROMOCRIPTINE TREATMENT IN ACROMEGALY: CLINICAL AND BIOCHEMICAL EFFECTSActa Endocrinologica, 1977
- LONG-TERM TREATMENT WITH 2—Br—α—ERGOCRYPTINE IN ACROMEGALYActa Endocrinologica, 1977
- Bromocriptine treatment of acromegalyMetabolism, 1977
- Long-term treatment of acromegaly with bromocriptine.BMJ, 1977
- Metabolic and clinical studies on patients with acromegaly treated with bromocriptine over 22 monthsEuropean Journal of Clinical Investigation, 1977
- BROMOCRIPTINE THERAPY IN ACROMEGALYThe Lancet, 1975
- Bromocriptine treatment of acromegaly.BMJ, 1975